Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 11:24 AM ET


Company Overview of OptiNose AS

Company Overview

OptiNose AS, a drug delivery company, offers research and development for nasal drug and vaccine delivery devices for pharmaceutical and biotech companies. The company offers single and multi-use intranasal delivery devices for liquid and powder formulations. Its nasal drug delivery devices enable nasal administration of central nervous system, systemic, and topical nasal formulations; and breath actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and olfactory regions. OptiNose AS was founded in 2000 and is based in Oslo, Norway.

Austliveien 1 Røa

Oslo,  0702


Founded in 2000


47 22 51 59 00


47 22 13 15 01

Key Executives for OptiNose AS

Chief Executive Officer and Director
Age: 54
Co-Founder and Chief Scientific Officer
Vice President of Operations & Program Management
Head of Device Development
Compensation as of Fiscal Year 2015.

OptiNose AS Key Developments

OptiNose AS Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM

OptiNose AS Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Peter K. Miller, Chief Executive Officer and Director.

OptiNose Announces Management Changes

OptiNose announced three appointments to the company's senior management team. Ramona Lloyd, Ph.D. has joined the company as Vice President, Regulatory Affairs & Quality. Dr. Lloyd has held executive leadership positions in Regulatory Affairs and Quality with such companies as Sanofi-Aventis, Bristol Myers-Squibb, and Johnson & Johnson. Sheila Bergey has joined the company as Vice President, Operations & Program Management. Mrs. Bergey spent 25 years with Johnson & Johnson where she held leadership positions in Operations, Supply Chain, Change Management -- including Strategic Planning, Program Management, Information Technology, Process Excellence and Procurement. Terrence Terifay has joined the company as Senior Vice President and Chief Commercial Officer. Most recently, Mr. Terifay held commercial leadership positions at Mallinckrodt, including Vice President, Marketing and interim General Manager, Branded Specialty Pharmaceuticals.

Similar Private Companies By Industry

Company Name Region
O3C Nutratceuticals AS Europe
MSD Animal Health Innovation AS Europe
OptiNose AS Europe
Ayanda Group AS Europe
Bio-Medisinsk Innovasjon AS Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OptiNose AS, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at